Impact Biomedicines, Inc.

Organization

Summit, NJ, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Methods of treating myeloproliferative disorders
- Patent number 11,400,092
- Issue date Aug 2, 2022
- Impact Biomedicines, Inc.
- Tymara Berry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for treating myelofibrosis
- Patent number 10,391,094
- Issue date Aug 27, 2019
- Impact Biomedicines, Inc.
- Arvind Jayan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS
- Publication number 20240293406
- Publication date Sep 5, 2024
- Impact Biomedicines, Inc.
- Arvind Jayan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DOSING OF FEDRATINIB
- Publication number 20240058336
- Publication date Feb 22, 2024
- Impact Biomedicines, Inc.
- Gopal KRISHNA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTALLINE FORMS OF A JAK2 INHIBITOR
- Publication number 20220332706
- Publication date Oct 20, 2022
- Impact Biomedicines, Inc.
- Benoit Robert
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BET INHIBITORS AS A TREATMENT FOR MYELOFIBROSIS
- Publication number 20220265617
- Publication date Aug 25, 2022
- Impact Biomedicines, Inc.
- Ida Aronchik
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING MYELOPROLIFERATIVE DISORDERS
- Publication number 20220133724
- Publication date May 5, 2022
- Impact Biomedicines, Inc.
- Tymara Berry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING MYELOPROLIFERATIVE DISORDERS
- Publication number 20220133751
- Publication date May 5, 2022
- Impact Biomedicines, Inc.
- Torsten Guenter Gerike
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING MYELOPROLIFERATIVE DISORDERS
- Publication number 20220031713
- Publication date Feb 3, 2022
- Impact Biomedicines, Inc.
- Torsten Guenter Gerike
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING MYELOPROLIFERATIVE DISORDERS
- Publication number 20220031699
- Publication date Feb 3, 2022
- Impact Biomedicines, Inc.
- Tymara Berry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS
- Publication number 20210244735
- Publication date Aug 12, 2021
- Impact Biomedicines, Inc.
- Arvind Jayan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS
- Publication number 20190381041
- Publication date Dec 19, 2019
- Impact Biomedicines, Inc.
- Arvind Jayan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
88886323 - INREBIC
- Serial number 88886323
- Filing date Apr 24, 2020
- Impact Biomedicines, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88886318 - INREBIC
- Serial number 88886318
- Filing date Apr 24, 2020
- Impact Biomedicines, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
88207119 - INREBIC
- Serial number 88207119
- Registration number 5962898
- Filing date Nov 27, 2018
- IMPACT BIOMEDICINES, INC.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87722697 - ZELESPRA
- Serial number 87722697
- Filing date Dec 15, 2017
- Impact Biomedicines, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
87722685 - REZNUVI
- Serial number 87722685
- Filing date Dec 15, 2017
- Impact Biomedicines, Inc.
- 5 - Pharmaceutical and veterinary preparations

Impact Biomedicines, Inc.

Organization

Patents Grantslast 30 patents

Methods of treating myeloproliferative disorders

Compositions and methods for treating myelofibrosis

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS

DOSING OF FEDRATINIB

CRYSTALLINE FORMS OF A JAK2 INHIBITOR

BET INHIBITORS AS A TREATMENT FOR MYELOFIBROSIS

METHODS OF TREATING MYELOPROLIFERATIVE DISORDERS

METHODS OF TREATING MYELOPROLIFERATIVE DISORDERS

METHODS OF TREATING MYELOPROLIFERATIVE DISORDERS

METHODS OF TREATING MYELOPROLIFERATIVE DISORDERS

COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS

COMPOSITIONS AND METHODS FOR TREATING MYELOFIBROSIS

Trademarklast 30 trademarks

88886323 - INREBIC

88886318 - INREBIC

88207119 - INREBIC

87722697 - ZELESPRA

87722685 - REZNUVI